UniSa - IRIS Institutional Research Information System

PERSICO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.225
NA - Nord America 13.243
EU - Europa 4.326
SA - Sud America 1.006
Continente sconosciuto - Info sul continente non disponibili 394
AF - Africa 177
OC - Oceania 20
Totale 34.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.821
HK - Hong Kong 9.786
SG - Singapore 2.448
IT - Italia 1.669
CN - Cina 1.243
BR - Brasile 767
VN - Vietnam 706
UA - Ucraina 649
RU - Federazione Russa 445
DE - Germania 354
FR - Francia 252
IE - Irlanda 246
CA - Canada 233
KR - Corea 231
FI - Finlandia 176
TR - Turchia 173
SE - Svezia 134
GB - Regno Unito 124
BD - Bangladesh 116
IN - India 114
AR - Argentina 91
JP - Giappone 85
MX - Messico 71
ZA - Sudafrica 56
IQ - Iraq 49
ES - Italia 42
NL - Olanda 41
ID - Indonesia 40
EC - Ecuador 39
PL - Polonia 36
AT - Austria 33
CO - Colombia 31
VE - Venezuela 31
PK - Pakistan 28
DK - Danimarca 27
IL - Israele 27
JM - Giamaica 26
CR - Costa Rica 21
SA - Arabia Saudita 20
MA - Marocco 18
MY - Malesia 18
EG - Egitto 17
GT - Guatemala 17
UZ - Uzbekistan 17
PY - Paraguay 16
AU - Australia 15
TW - Taiwan 15
HN - Honduras 14
PH - Filippine 14
LT - Lituania 13
AZ - Azerbaigian 12
DZ - Algeria 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JO - Giordania 11
KE - Kenya 11
RO - Romania 11
TN - Tunisia 11
PE - Perù 10
AL - Albania 9
CL - Cile 9
SC - Seychelles 9
KZ - Kazakistan 8
PS - Palestinian Territory 8
BE - Belgio 7
GR - Grecia 7
OM - Oman 7
PT - Portogallo 7
SN - Senegal 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
EU - Europa 6
NI - Nicaragua 6
BO - Bolivia 5
NO - Norvegia 5
UG - Uganda 5
BB - Barbados 4
BH - Bahrain 4
BS - Bahamas 4
CG - Congo 4
LB - Libano 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
EE - Estonia 3
ET - Etiopia 3
GY - Guiana 3
IR - Iran 3
LY - Libia 3
ME - Montenegro 3
MW - Malawi 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
RS - Serbia 3
AF - Afghanistan, Repubblica islamica di 2
Totale 33.952
Salva come PNG Salva come JPEG
Città #
Hong Kong 9.737
Ann Arbor 1.681
San Jose 1.639
Singapore 1.278
Chandler 840
Jacksonville 825
Princeton 723
Ashburn 690
Milan 613
Woodbridge 521
Dallas 485
Council Bluffs 483
Wilmington 366
Houston 315
Beijing 306
The Dalles 254
Dublin 238
Dong Ket 217
Lauterbourg 204
New York 196
Rome 168
Andover 164
Ho Chi Minh City 163
Los Angeles 157
Nanjing 147
Izmir 143
Santa Clara 132
Pellezzano 128
Boardman 123
Hanoi 109
Moscow 95
Naples 78
São Paulo 78
Munich 75
Memphis 70
Salerno 67
Tokyo 66
Hebei 55
Shenyang 54
Denver 50
Montreal 49
Ottawa 49
Phoenix 49
Brooklyn 48
Figino 46
Changsha 45
Columbus 45
Fairfield 45
Norwalk 44
Nanchang 42
Atlanta 39
Jiaxing 39
Chicago 38
Turin 38
Frankfurt am Main 34
Düsseldorf 33
Redwood City 33
Orem 32
Seattle 32
Stockholm 32
Mexico City 31
Nuremberg 31
Washington 31
Johannesburg 30
Toronto 30
Tianjin 29
Chennai 28
Jinan 28
Warsaw 28
London 27
Rio de Janeiro 26
Turku 26
Mestre 25
Da Nang 24
Haiphong 24
Belo Horizonte 22
Boston 22
Guangzhou 21
Amsterdam 20
Brasília 20
Dhaka 20
Falls Church 20
North Charleston 20
San Diego 20
Dearborn 19
San Francisco 19
Charlotte 18
Curitiba 17
Helsinki 17
Manchester 17
San José 17
Baghdad 16
Kingston 16
Shanghai 15
Tashkent 15
Vienna 15
Caracas 14
Cambridge 13
Cincinnati 13
Guayaquil 13
Totale 25.402
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 984
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 785
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 781
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 725
Non Alcoholic Fatty Liver: Epidemiology and Natural History 638
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 618
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 585
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? 526
Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects. 513
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 448
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. 428
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 414
Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma 413
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 386
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 379
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 355
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 338
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 330
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 330
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 321
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 313
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma 304
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 303
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. 301
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 275
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 224
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 204
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 199
The diagnostic conundrum in non-alcoholic fatty liver disease 197
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 195
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 195
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 193
Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. 185
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 173
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 166
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 165
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 163
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 162
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 162
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 158
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 158
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach]. 157
Coeliac disease and C virus-related chronic hepatitis: a non association 157
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. 155
Alcoholic Liver Disease and Hepatitis C Chronic Infection 153
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 151
Effect of different doses of S-adenosyl-L-methionine (SAMe) on nicotinic acid-induced hyperbilirubinaemia in Gilbert's syndrome. 149
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 149
Epidemiology and Natural History of Alcoholic Liver Disease 148
Adiponectin in hepatology 148
Pharmacotherapy of alcoholic liver disease in clinical practice 147
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 145
A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection. 143
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 140
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy 139
Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). 138
[Diabetic neuropathies. IV. Autonomous neuropathy. Peripheral sympathetic innervation and the cardiovascular system]. 138
Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. 137
154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY 137
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 137
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy 137
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 136
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 134
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 134
Risk factors for hospital readmission of elderly patients. 133
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea 133
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 133
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 132
Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. 130
Electrophysiological evidence for Na+-coupled bicarbonate transport in cultured rat hepatocytes 130
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 130
478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 130
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 129
A randomised controlled trial on pegylated interferon alfa-2a (40kd)(Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 128
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 126
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 126
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 126
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 126
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 126
Viral hepatitis: Milestones, unresolved issues, and future goals 126
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C 124
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis 124
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? 124
Metabolic associated steatotic liver disease in renal transplant recipients: a retrospective cohort study 123
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 123
Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. 122
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno 122
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. 121
Na+-H+ exchange activity in rat hepatocytes: Role in regulation of intracellular pH 119
Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. 119
Steatosis as a co-factor in chronic liver diseases 119
Dose dependence of nicotinic acid-induced hyperbilirubinemia and its dissociation from hemolysis in Gilbert's syndrome. 118
Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. 118
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 118
HCV antiviral therapy in injection drug users: difficult to treat or easy to cure? 118
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells 117
Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis. 117
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system]. 116
[Diabetic neuropathy. III: Autonomic neuropathy. Genito-urinary system]. 116
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy 116
Totale 22.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.225 0 0 0 0 26 24 34 58 193 169 156 565
2022/20232.009 207 118 63 237 291 430 12 185 301 5 108 52
2023/2024890 82 120 69 32 71 140 32 44 8 34 51 207
2024/20252.756 73 46 56 118 152 290 434 323 486 170 291 317
2025/202618.202 1.663 4.630 4.623 550 1.186 593 1.750 346 548 911 302 1.100
2026/20272.826 360 323 1.033 1.021 89 0 0 0 0 0 0 0
Totale 34.391